Healthcare Services

Gastroparesis Market: Industry Growth and Forecast Trends

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Gastroparesis Market In 2026, And How Will Its Value Evolve By 2030?

The gastroparesis market size has seen robust growth in recent years. It is expected to expand from $7.15 billion in 2025 to $7.52 billion in 2026, showing a compound annual growth rate (CAGR) of 5.1%. The increase observed in the past can be attributed to elements like diabetes-related gastric disorders, the application of antiemetic medications, hospital-based GI care, dietary management strategies, and the widespread availability of diagnostic imaging.

The gastroparesis market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $9.29 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. Factors driving this growth during the forecast period include advancements in implantable stimulation devices, the expansion of outpatient treatment approaches, an increasing diabetic populace, the need for therapies targeting specific symptoms, and enhanced clinical understanding. Key trends anticipated over the forecast period encompass a greater reliance on prokinetic drugs, the increasing integration of gastric electrical stimulation devices, a heightened emphasis on managing diet and lifestyle, the availability of more minimally invasive surgical solutions, and more accurate diagnosis of diabetic gastroparesis.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Which Factors Are Influencing The Growth Of The Gastroparesis Market?

The accelerating rise in diabetes cases is projected to drive the gastroparesis market’s growth. Diabetes is a persistent health condition defined by elevated blood sugar levels, stemming from the body’s inability to produce adequate insulin or utilize it effectively. The widespread occurrence of diabetes substantially heightens the chance of developing gastroparesis, given its critical role in expanding the at-risk population. For example, in April 2025, the International Diabetes Federation, an advocacy organization based in Belgium, reported that globally, almost one in nine adults (589 million) are currently living with diabetes. An estimated 252 million of these individuals are unaware of their condition, putting them at greater risk of severe complications and early death. Thus, the swift increase in diabetes prevalence is fueling the gastroparesis market.

How Is The Gastroparesis Market Segmented Across Different Segment Categories?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

Which Trends Are Influencing Demand In The Gastroparesis Market?

Companies operating within the gastroparesis market are actively developing drugs to enhance their profitability. Drugs utilized for gastroparesis treatment serve various functions to alleviate symptoms associated with delayed stomach emptying. For instance, in December 2023, Vanda Pharmaceuticals Inc., a US-based Biopharmaceutical Company, announced that the U.S. FDA accepted the New Drug Application for Tradipitant, which represents a promising step toward its potential approval for treating gastroparesis. The FDA has set September 18, 2024, as the decision date for Tradipitant under the Prescription Drug User Fee Act (PDUFA). If approved, Tradipitant would become the first novel FDA-approved drug for gastroparesis in over 40 years, marking a significant milestone as it would be the first drug in more than three decades to specifically undergo FDA review for gastroparesis.

Which Organizations Play A Role In The Gastroparesis Market Landscape?

Major companies operating in the gastroparesis market are Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Get The Full Gastroparesis Market Report:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Which Region Holds The Highest Market Share In The Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2025. The regions covered in the gastroparesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gastroparesis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Browse Through More Reports Similar to the Global Gastroparesis Market 2026, By The Business Research Company

Gastric Volvulus Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Gastroparesis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

Diabetic Gastroparesis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795